URGN UroGen Pharma: Company Short-Term Debts

Symbol and logo of brand UroGen Pharma Ltd. (URGN)

The UroGen Pharma Ltd. (URGN) short-term liabilities chart shows a figure of 0.00. The business relies on alliances with specialized institutions and clinics to implement targeted drug delivery. UroGen Pharma Ltd. (URGN) is developing its own RTGel hydrogel system, creating a sustainable ecosystem for urological tumor therapy. The humanitarian profile of the products minimizes the impact of trade wars, ensuring stable component supplies in allied markets.

URGN UroGen Pharma Ltd Company Short-Term Loans and Borrowings (07/04/2022 - 10/31/2026)

URGN (UroGen Pharma Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price UroGen Pharma|URGN - Consensus Target
- company stock capitalization data:
Market Capitalization UroGen Pharma Ltd.|URGN - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share UroGen Pharma|URGN - Accounting Value of Company|Market Cap to Net Assets Ratio urogen.com|URGN - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital UroGen Pharma Ltd.|URGN - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio UroGen Pharma Ltd.|URGN - Company Aggregate Debts|Debt to Book Capitalization Ratio UroGen Pharma Ltd.|URGN - Company Long-Term Loans and Borrowings|Company Short-Term Debts UroGen Pharma|Quick Liquidity Indicator urogen.com
- earnings and multiples data:
URGN - Net Profit
Analysis of all company metrics:URGN - UroGen Pharma
Manufactured products of urogen.com

Investors assess long-term business viability through the lens of current solvency. This metric aggregates all credit obligations maturing within one year to measure the risk of a liquidity gap. By analyzing the volume of short-term liabilities, one can determine the company's dependence on the cost of borrowed capital. For UroGen Pharma Ltd. (URGN), this balance is critical for controlling cash burn. Liquidity stability directly impacts the successful commercialization of Jelmyto and the development of UGN-102.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|BCAX: Company Short-Term Loans and Borrowings|Company Current Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts DCTH (Delcath)|YMAB - Company Current Liabilities|AURA: Company Current Liabilities|CADL - Company Short-Term Debts|Accuray (ARAY) - Company Short-Term Debt|SELLAS Life Sciences Group - Company Short-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Current Liabilities HURA (TuHURA Biosciences, Inc.)|Company Short-Term Debts protaratx.com (TARA)|Company Short-Term Debt Fate Therapeutics FATE|Company Short-Term Loans and Borrowings WHWK|TCRX - Company Short-Term Debt|Short-Term Debt Champions Oncology|XBIT: Company Short-Term Debts|Short-Term Indebtedness CEL-SCI CVM|OSTX (OS Therapies) - Company Short-Term Debts|Short-Term Debt Radiopharm Theranostics Ltd RADX|Company Short-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|adlainortye.com - Company Short-Term Indebtedness|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|XLO - Company Short-Term Debt|Current Liabilities RENB|MURA: Company Short-Term Debts|Kairos Pharma - Company Short-Term Loans and Borrowings|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts CytoMed|Company Short-Term Debt Curis, Inc. (CRIS)|APLM (apollomicsinc.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Tharimmune Corp THAR|ADVB - Company Current Liabilities|Genprex, Inc. - Company Short-Term Debts|CLDI - Company Short-Term Debts|SBFM (Sunshine Biopharma) - Company Current Liabilities|Xenetic Biosciences, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Salarius|Company Short-Term Debt PPBT|Company Current Liabilities AONC (American Oncology Network)|Amount of Current Liabilities BGNE|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|ELEV: Company Short-Term Indebtedness|ICAD: Company Current Liabilities|Short-Term Debt Volume Ikena Oncology, Inc. IKNA|NTBL (Notable Labs, Ltd.) - Company Current Liabilities|Viracta Therapeutics, Inc. (VIRX) - Company Short-Term Debts|Company Short-Term Debt MorphoSys|NAYA: Company Short-Term Loans and Borrowings|Company Short-Term Debts AAPGV